In vitro cytotoxicity of NK-92/5.28.z and NK-92-scFv-erbB2-CD28-ζ cells against HER2-expressing cancer cells reached a plateau at E:T ratios of 10:1 and 20:1, respectively [37,38]. Here, ERBB2 is linked to cancer.